Application of Local Melatonin in Peri-implantitis
Status:
COMPLETED
Trial end date:
2023-07-15
Target enrollment:
Participant gender:
Summary
A randomized clinical trial was carried out in patients affected by peri-implantitis with a follow-up of 60 days. Melatonin 1.9 mg or placebo was applied locally to the peri-implant defect after nonsurgical debridement.
To determine the effectiveness anti-inflammatory, osteogenic and antimicrobial properties were evaluated. The probing depth, bleeding index, plaque index, and interleukin-1 and 6 concentrations, peri-implant bone level and the bacterial strains were analyzed.